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Introduction
When combined with severe vesico-ureteric reflux, intrarenal reflux has been shown clinically in young children (Rolleston, Maling & Hodson, 1974; Rolleston, Shannon & Utley, 1975) and experimentally in pigs (Hodson, Craven, Lewis, Matz, Clark & Ross, 1969) to be associated with the production of severe renal scarring identical with that of atrophic pyelonephritis.
In the child, this scarring occurs mainly in the first 5 years of life (Bailey, 1973; Hodson & Wilson, 1965; Rolleston et al., 1975 ) and, since the major cause of reflux is a congenital malformation, action to prevent it should be taken in the early post-natal period. The problem is one of early detection. Investigation for vesicoureteric reflux is usually initiated because of bacteriuria or symptoms of urinary tract infection and is confirmed by cystographic procedures. However, there is evidence that not all children with reflux, even those with severe grades, have had symptoms of urinary tract infection, as some have been discovered by the investigation of family members of refluxers (Frye, Pate1 & Parsons, 1974) . In the experimental animal, scarring similar to that found in humans has been produced in the absence of any infection (Hodson, Maling, McManamon & Lewis, 1975) .
The radiological picture presented by the kidney during intrarenal reflux indicates that, under these conditions, formed urine (i.e. the final product of excretion from the kidney) may enter the interstitium of the kidney and then, via the lymphatics or blood vessels, enter the circulation.
Formed urine contains a glycoprotein first described by Tamm & Horsfall (1950) and P . J. G. Avis existing, in its native state, as a high-molecularweight polymer ( > 7 x lo6) composed of subunits of molecular weight of the orders of 8 x lo4 (Fletcher, Neuberger & Ratcliffe, 1970b) . It can be dissociated with a variety of reagents, leaving its antigenic properties intact (Stevenson &Kent, 1970; Marr, Neuberger &Ratcliffe, 1971) .
Tamm-Horsfall glycoprotein is secreted by the cells lining the ascending loop of Henle and the distal convoluted tubule (Pollak & Arbel, 1969; Schrenk, Schwartz & Lewis, 1971 ) and has been reported to be absent from the normal sera (Vaerman & Heremans, 1959; Keutel & King, 1963; Schwartz & Pallavicine, 1967) and other secretions of the urogenital system (Grant, 1959) .
If formed urine does get into the circulation during intrarenal reflux, it should contain THglycoprotein and the presence of this substance in the circulation might provide evidence of this condition. In view of the often expressed need for a simple test for intrarenal reflux, a sensitive test for TH-glycoprotein in serum has been developed.
Materials

Tamm-Hors fall glycoprotein
Human TH-glycoprotein was precipitated from pooled samples of urine from male medical students by the addition of NaCl to bring the final concentration to 580 mmol/l. The precipitate was collected by centrifugation, taken up in distilled water and dialysed against three changes of 20 vol. of distilled water at 12 h intervals. The viscous solution contained some insoluble pigmented material which was removed by centrifugation (20 min at 12 OOO g).
The glycoprotein was then precipitated by the addition of an equal volume of NaCl (1.16 molll), taken up in distilled water and dialysed as before. After a further precipitation and dialysis the solution was centrifuged for 20 min at 12 OOO g and the supernatant was removed and freeze-dried.
Antisera
Antibodies were raised to freeze-dried human TH-glycoprotein in rabbits by intramuscular injection of 2 ml of equal volumes of Freunds adjuvant and a solution of the glycoprotein containing 1 mg of freeze-dried preparation. The dose was divided into 0.5 ml lots and given at four separate sites. After 4 weeks the rabbits were given a further injection of the same amount of TH-glycoprotein in incomplete Freunds adjuvant. The rabbits were bled 2 weeks after the second injection. Sodium azide (0.1 mg/ml) was added as a preservative and the serum stored at 4°C until used.
Preparation of immunoabsorbents
(1) Rabbit freeze-dried gammaglobulin fraction prepared by ammonium sulphate precipitation from anti-(human TH-glycoprotein) serum or from normal rabbit serum was coupled to cyanogen bromide-activated agarose ( h e n , Porath & Ernbach, 1967). The cyanogen bromide-agarose was obtained from Pharmacia (CNBr-activated Sepharose 4B; Sepharosel CNBr). The gammaglobulin (20 mg/ml of swollen agarose gel) was dissolved in a volume of carbonate/bicarbonate buffer (100 mmol/l), pH 8.6, containing NaCl(500 mmol/l), equal to twice the volume of swollen Sepharose/CNBr. The SepharoselCNBr was activated by suspending the freeze-dried powder in HCI (1 mmol/1) and washing on a glass filter with 200 ml of HCI (1 mmol/l) per g of Sepharose over a period of 15 min. The gel was drained of all surplus liquid and transferred to a beaker containing the protein solution. After rapid mixing the suspension was allowed to react overnight at 4°C with sufficient agitation to keep the Sepharose beads in suspension. Uncoupled protein was removed by washing the Sepharose with carbonate/bicarbonate buffer containing NaCI, several times on a glass filter. Any remaining active groups were blocked by treatment with ethanolamine (1 mol/l), pH 8, for 2 hat room temperature. The final product was washed four times alternately with borate buffer (100 mmol/l), pH 8-5, and acetate buffer (100 mmol/l), pH 4.0, each buffer withNaCl added (1 mol/l). Thematerialwasthen stored in Trislglycine buffer, pH7.2, until used.
(2) Freeze-dried TH-glycoprotein was coupled to SepharoseKNBr. For use in the preparation of specific anti-TH antibodies 15 mg of freezedried TH-glycoprotein/ml of swollen Sepharosel CNBr was dissolved in 1.5 ml of carbonatelbicarbonate buffer (100 mmol/l), pH 8.6, containing sodium dodecyl sulphate (10 g/l), and allowed to stand for 1 h. Sepharose/CNBr was activated by suspending the freeze-dried powder in HCl(1 mmol/l) and washing on a glass filter with 200 ml of HCI (1 mmol/l)/g of Sepharosel CNBr over a period of 15 min. The gel was then suspended, in a volume equal to 1.5 times the volume of swollen gel of carbonate/bicarbonate buffer (100 mmol/l), pH 8.6. The treated THglycoprotein solution was added and allowed to react at 4°C overnight with sufficient agitation to keep the gel particles in suspension. Uncoupled protein was removed by washing once with several volumes of carbonate/bicarbonate buffer and twice with distilled water. Any remaining active groups were blocked by treatment with ethanolamine (1 molll) adjusted to pH 8. The final product was washed alternately with Tris/HCl buffer (100 mmol/l), pH 7.2, and acetate buffer (100 mmol/l), pH 4, each with the addition of NaCl(200 mmolll). The material was stored at 4°C in Tris/HCl buffer, with the addition of sodium azide to a concentration of 1 part in 5000, until used. For the preparation of the solid phase used in the radioimmunoassay TH-glycoprotein was coupled to Sepharosel CNBr without prior treatment with sodium dodecyl sulphate.
Methods and results
Immunodiffusion
Ouchterlony plates for double-diffusion studies were prepared with 1 % immunodiflusion agar in barbitone buffer (50 mmol/l), pH 8.6. Samples of freeze-dried TH-glycoprotein (1 mg) were dissolved in 1 ml of Tris/glycine buffer (100 mmol/l) containing the dissociating agent sodium dodecyl sulphate (10 g/l) to facilitate diffusion of the glycoprotein through the gel. The antisera used in these studies were examined by Ouchterlony double diffusion over a range of dilutions and gave a single line of precipitation. A second line that appeared near the antibody well was shown to be due to a non-specific reaction between sodium dodecyl sulphate and rabbit serum. There was no demonstrable reaction between the rabbit antisera and normal human serum or between TH-glycoprotein and anti-orosomucoid.
Specific anti-(TH-glycoprotein) antibodies
A small column (12 mm diam. x 6 5 mm) was packed with about 5 ml of Sepharose-TH immunoabsorbent and washed through with 20 ml of Tris/HCl buffer (200 mmol/l), pH 8, with the addition of NaCl(500 mmol/l). Rabbit antiserum to TH-glycoprotein (3 ml) was applied to the column. The flow rate of the column was adjusted to about 3 dropslmin until the serum had passed into the column. The serum was then washed into the column with a small volume of the Tris/HCl buffer; the top of the column was then covered with Tris/HCl buffer. The column flow was stopped and the serum allowed to remain in contact with the absorbent for 30 min at room temperature. The column was then washed through with the Tris/HCl buffer containing NaCl (500 mmol/l) until the monitored effluent was free of material absorbing at 280 nm.
Specific antibody was eluted with MgC12 (45 mol/l)/Tris (100 mmolll). Fractions of 1 ml were collected. The fractions comprising the single peak eluted by MgCL (4.5 mol/l) were pooled, placed in a dialysis sac of 4 in cellulose tubing and dialysed against glycine (2.5 mol/l)/ Tris (200 mmol/l)/HCl buffer, pH 7-2. It was found that dialysis against this buffer eliminated losses encountered when dialysis was performed with other buffers such as phosphate (10 mmolll) in NaCl solution (150 mmol), pH 7.2. After dialysis thespecific antibodies were concentrated in an Amicon cell to a concentration of 1 mg of proteinlml. Aliquots of 100 pl were dispensed in plastic tubes and stored in liquid nitrogen.
lodination of the specific anti-( TH-glycoprotein) antibody
The lactoperoxidase method of Marchalonis (1969) was used. An aliquot of specific antibody containing 100 pg of protein in 100 p1 of glycine (2.5 mol/l)/Tris (200 mmol/l)/HCl buffer pH 7.2, was made to react with 0.5 mCi of lZ5I in 5 p1 of NaOH (100 mmol/l) adjusted to a specific radioactivity of 6 mCi/pg of iodine by the addition of sodium iodide.
The tube containing the specific antibody was thawed rapidly in a water bath. Lactoperoxidase (2 pl), with an activity of 100 i.u./ml (Calbiochem B grade), was added followed by 5 pl of a solution of [12SI]iodate in NaOH (100 mmol/l). After mixing, 2 pl of hydrogen peroxide solution (8.8 mmol/l) was added. The mixture was allowed to react for 10 min, after which a further 1 p1 of hydrogen peroxide was added.
The mixture was allowed to react for a further 5 min, and then 0.5 ml of mercaptoethanol (5 mmol/l) was added. After a further 5 min 0.6 ml of a solution of bovine serum albumin (Difco 30% bovine serum albumin solution) was added. The reaction mixture was transferred to a dialysis sac and dialysed against 1 litre of glycine (1 mol/l)/Tris (100 mmol/l)/HCl buffer overnight. The dialysis buffer was changed and dialysis continued for a further 6 h. The labelled antibody was removed from the dialysis sac and made up to 2 ml with the glycine/Tris/HCl buffer. Sodium azide, at a concentration of 0.1 mg/ml, was added as a preservative. The labelled antibody was stored at 4°C and was usable for a period of 2 months. Under the conditions described and with the reagents specified, a specific radioactivity of 125 pCi/pg was achieved. It was found that the high concentration of albumin and the use of glycine (1 mol/l) contributed to the stability of the specific antibody during storage.
Selection of radioimmunoassay procedure
The procedure for the determination of THglycoprotein in urine was based on the method described by Grant & Neuberger (1973) . These authors used a system involving antibodycoated tubes and iodinated TH-glycoprotein. In the presence of albumin concentrations greater than 100 pglml, however, anomalous results were obtained. In a similar type of assay for growth hormone (Baumann, Girard & Vest, 1969) non-specific effects were described when the concentration of plasma protein exceeded 120 pg/ml. Since the assay was to be performed in the presence of much higher concentrations of serum proteins (i.e. above 35 mglml), this system was unsuitable. Another factor was the sensitivity. The range of TH-glycoprotein concentration in urine is 150-2270 ng/ml, whereas it was estimated that the amount of THglycoprotein in serum due to reflux or tubular damage might be of the order of 5-20 ng/ml. Several attempts to iodinate TH-glycoprotein did not achieve the required specific radioactivity for it to be used as the labelled component in any assay system to detect TH-glycoprotein in the range 5-50 ng.
The advantages of using a system where one of the components of the antibodylantigen system is bound to a solid phase is that the bound component is easily removed from the unchanged material by centrifugation and subsequent manipulation is more easily performed.
It was decided to use iodinated specific anti-(TH-glycoprotein) antibody as the labelled component and TH-glycoprotein bound to Sepharose as the solid phase.
Optimum concentrations of antigen and antibody
The concentrations of the reactants in the radioimmunoassay were determined by the required sensitivity. If either antigen bound to Sepharose or antibody in solution were not in excess, an equilibrium would be established between the antibody bound to the solid-phase antigen, free antibody and unoccupied antigen sites on the solid phase. The addition of soluble antigen would compete with the bound antigen for labelled antibody, resulting in a reduction in the amount of labelled antibody bound to the solid phase. Any antibodylantigen complexes formed as a result of the introduction of the soluble antigen would not be sedimented at the centrifugal forces used to sediment the Sepharose beads.
It was assumed that because the amount of TH-glycoprotein to be detected would be in the range 0-50 ng, the amount of antigen bound to Sepharose used in the assay would also be in the range 0-50 ng. By use of the above value as a guide-line a number of immunoabsorbents were prepared in which amounts of TH-glycoprotein in the range 20-200 pg were made to react with 5 ml of CNBr-activated Sepharose 4B. Because of the small amounts involved it was not possible to determine the actual amount of TH-glycoprotein that combined with the Sepharose. The immunoabsorbents were suspended in Tris/HCI buffer (200 mmol/l), pH 7.4, as a 5 % suspension with sodium azide as a preservative. The immunoabsorbents could be stored at 4°C for 4 months without deterioration.
A number of experiments were performed with the immunoabsorbents described in various amounts and with a range of labelled antibody concentrations. As a result of these experiments the immunoabsorbent prepared with 50 pg of TH-glycoprotein was selected for further study.
The amount of TH-glycoprotein available for reaction was estimated by allowing 0.1 ml of SepharoselTH-glycoprotein suspension (5 g/l) to react in the presence of an excess of labelled specific antibody. The maximum amount of specific antibody combining with 0.1 ml of the Sepharose/TH-glycoprotein suspension was 21.25 ng. A similar experiment was performed with the immunoabsorbent in excess and an amount of labelled specific antibody equal to 50 ng. The maximum amount of labelled antibody bound was equal to 42% of the total, or 21 ng.
The above formed the basis for the method described here. The immunoabsorbent used was as described and the labelled specific antibody used was diluted in Tris/HCl buffer (200 mmol/l), pH 8, containing NaCl (500 mmol/l) and 2% foetal calf serum, so that 0.1 ml contained 50 ng of antibody protein (50 pl of labelled antibody solution to 5 ml of buffer).
Experiments with different preparations of specific antibody and immunoabsorbent showed that similar overall results were obtained when the amount of specific antibody combining with 0.1 ml of the absorbent was within the range 10-30 ng.
Radioimmunoassay procedure
The substance undergoing test was made up to a volume of 0.5 ml with Tris/HCl buffer (200 mmol/l), pH 8, containing NaCl (500 mmol/l), foetal calf serum (2%, v/v) and Tween 80 (1 g/l) in a 11 mm x 63 mm plastic tube. The labelled antibody (0.1 ml containing 50 ng of antibody protein) was added and the tubes were shaken to ensure mixing. Last, 0.1 ml of a suspension of the Sepharose/TH-glycoprotein (5 g/l) was added.
The tubes were tightly capped and placed on a rotator overnight (16 h) at room temperature just sufficient to keep the beads in suspension.
After incubation the tubes were centrifuged with their caps on at lo00 g for 4 min and were then filled to within 3 mm of the top with NaCl (500 mmol/l) and centrifuged again with the caps off. The supernatant was removed with the aid of a stainless-steel tube fitted with a collar so that the supernatant was removed to within 5 mm of the bottom of the tube. The Sepharose was then washed three times with NaCl solution, the supernatant being removed as before. Finally the radioactivity in the tubes was counted in a gamma spectrophotometer.
Calibration curues
By use of the above procedure, calibration curves were constructed over a range of THglycoprotein concentrations between 2 and 100 ng. The TH-glycoprotein was diluted either from a standard solution of freeze-dried THglycoprotein in water or from a standard sohtion in sodium dodecyl sulphate. The assays were repeated in the presence of normal human serum that had been absorbed with rabbit anti-(human TH-glycoprotein) gammaglobulk, attached to Sepharose.
The results were plotted as the ratio of radioactivity (c.p.m.) of the test samp1elc.p.m. of a control that consisted of buffer, iodinated antibody and Sepharose/TH-glycoprotein. It can be seen (Fig. la) that the calibration curve obtained with undissociated TH-glycoprotein showed a marked deflection at around 20 ng of the THglycoprotein, after which point increasing concentrations of TH-glycoprotein resulted in more labelled antibody being bound. In contrast, the curve (Fig. Id) obtained with TH-glycoprotein pretreated with sodium dodecyl sulphate shows a straight-line relation between amount of the antibody bound and the log concentration of TH-gl ycoprotein.
Near identical results were obtained with sodium dodecyl sulphate-treated TH-glycoprotein in the presence of normal human serum which had been absorbed to remove THglycoprotein (Fig. lc) .
Assay of TH-glycoprotein in human serum
Assays performed on sera from healthy volunteer subjects gave results that varied over a limited range but the amount of antibody bound was always less than the control without serum. After absorption of these sera with a rabbit anti-(human TH-glycoprotein) gammaglobulin preparation bound to Sepharose, the values for antibody bound were significantly increased ( Table 1 , column c). It can also be seen that the values obtained after absorption were within f4% of the mean value for all sera tested. Absorption of sera with normal rabbit gammaglobulins bound to Sepharose or by TH-glycoprotein bound to Sepharose had no significant effect. It was therefore assumed that there was a substance in normal serum identical with or closely resembling TH-glycoprotein. In order to characterize this substance further, two curves were constructed by adding known amounts of untreated TH-glycoprotein to absorbed and non-absorbed serum. The results are shown in Fig. 2 . The curves are nearly identical in slope but the curve of the unabsorbed serum is displaced such that it would indicate the presence of undegraded THglycoprotein.
As a further test of specificity, ten sera from healthy donors were treated by adding 0.05 ml (packed volume) of rabbit anti-(human THglycoprotein) immunoabsorbent to 0.25 ml of serum. The sera were placed on a rotator and incubated at room temperature for 2 h, followed by 2 h at 4°C. Foetal calf serum was used as a control. The immunoabsorbent was separated from the serum by centrifugation and washed three times with Tris/HC1 buffer (200 mmol/l), pH 8, in NaCl(500 mmol/l) and finally suspended in 0.5 ml of buffer. Iodinated specific anti-(human TH-glycoprotein) antibody of the same concentration as used for the immunoassay was added to each sample. The samples were incubated overnight on a rotator. The samples were centrifuged and the supernatant was removed; the immunoabsorbent was washed three times with saline. The washed immunoabsorbent was then counted for radioactivity in a gamma spectrophotometer. The results are shown as c.p.m. in Table 1 .
The same samples of sera were assayed in the Table 1 . The correlation coefficient ( r ) was calculated for the two sets of values. The result r = 0.93 shows an almost total inverse dependence of one value upon the other or, in other words, the substance present in serum that reacts with antibody to human TH-glycoprotein is responsible for the differing values obtained for the sera tested.
Dissociation of TH-glycoprotein in serum
It is evident from inspection of curve (a) in Fig. 1 and curves (a) and (b) in Fig. 2 that THglycoprotein, if present in serum, behaves as if it were in the high-molecular-weight form and that values obtained from the immunoassay procedure could be subject to misinterpretation: a value of 1.1 for instance could represent the equivalent of 2 ng of TH-glycoprotein or 34 ng of TH-glycoprotein. This problem does not arise if the TH-glycoprotein is dissociated by treatment with sodium dodecyl sulphate (Fig.  Id) .
In the procedure developed for the assay of TH-glycoprotein in urine (Grant & Neuberger, 1973) , sodium dodecyl sulphate at 11 mg/l and overnight incubation at 37°C was used to dissociate the TH-glycoprotein. This concentration of sodium dodecyl sulphate was then reduced by dilution to 5 mg/l before assay in order to obtain optimum slope and linearity. Owing to the high concentration of protein in the present assay, concentrations of sodium dodecyl sulphate of 10 g/l were not sufficient to dissociate TH-glycoprotein added to serum. The use of other chemical dissociating agents were equally unsuccessful in dissociating THglycoprotein in serum, if used at concentrations that would not affect the subsequent assay.
Native TH-glycoprotein is described as being composed of long unbranched linear arrays of subunits (Porter & Tamm, 1955; Maxfield, 1961 ; Bayer, 1964; Fletcher, McLaughlin, Ratcliffe &Woods, 1970a; Fletcher, 1972) . The possibility that ultrasonication could dissociate the TH-glycoprotein molecule was considered and a number of experiments were performed to establish optimum conditions. As a result of these experiments, it was found that subjecting either aqueous solution of TH-glycoprotein or TH-glycoprotein in serum to 1.5 min of ultrasonication at 20 W power at 20 kHz (Fig. lc) gave results similar to those obtained with sodium dodecyl sulphate-treated TH-glycoprotein. A certain amount of denaturation of serum proteins was indicated by the opacity of the serum after treatment, but this did not interfere with the assay. Comparison of normal serum subjected to ultrasonication with untreated sera showed only a slight decrease in amount of labelled antibody bound after ultrasonication (cf. Fig. l b and lc) .
Quantification
The radioactivity (c.p.m.) measured in the presence of serum absorbed with Sepharosel anti-(human TH-glycoprotein) absorbent were higher than those obtained for controls without absorbed serum. That this was due to the presence of protein was shown by substituting 7% bovine serum albumin for the absorbed serum. Standard curves were plotted by using 0.25 ml of bovine serum albumin (70 g/l) for absorbed human serum. It was found that the apparent affinity of sodium dodecyl sulphatetreated TH-glycoprotein for antibody increased within a time-scale of several hours. This problem was overcome by incubating THglycoprotein in the presence of sodium dodecyl sulphate as follows. TH-glycoprotein (0.1 mg/ml) was dissolved in distilled water. For the assay 1 ml of this solution was mixed with 1 ml of sodium dodecyl sulphate (10 g/l) and incubated for 24 h at 37°C. The incubated material was carefully washed into a 50 ml volumetric flask and the volume made up with distilled water, giving a final concentration of 2 pg/ml; various amounts of this solution, containing 2, 5, 10, 30, 50, 100 ng of TH-glycoprotein, were added to the 0.25 ml of 7% bovine serum albumin. The volume was made up to 0.5 ml with Tris/HCl buffer, pH 8, containing NaCl (500 mmol/l). The assay procedure was then carried out as described. The values of the mean count rate of the duplicate samples, as a percentage of the zero control, were plotted against the concentration of TH-glycoprotein plotted on a log scale. Assays of serum were performed in the described manner and the values of the mean count rate as percentages of the zero standard were read as ng of TH-glycoprotein/ml by reference to the standard curve (Fig. 3) . Results in ng-equivalent of TH-glycoprotein of normal sera are shown in Table 1 . 
Discussion
Undissociated TH-glycoprotein gave results that showed an apparent decrease in THglycoprotein concentration at amounts greater than 20 ng. This apparent decrease was manifest by more labelled antibody being bound to the TH-glycoprotein immunoabsorbent. In the presence of high-molecular-weight TH-glycoprotein, this would happen in two ways. (1) The TH-glycoprotein could form a complex with part of the labelled antibody, leaving antigenic sites unoccupied. This complex could then be bound to the immunoabsorbent by reaction of the antibody between antigenic sites on the complex and the immunoabsorbent. (2) The TH-glycoprotein could be linked to the immunoabsorbent by reaction of an antibody molecule between the antigenic site on the immunoabsorbent and the TH-glycoprotein molecule. This would effectively increase the number of available antigenic sites on the immunoabsorbent, since one molecule of TH-glycoprotein (mol. wt. 7 x lo6) would presumably possess at least 7 x lo3 potential binding sites if it were bound to the immunoabsorbent by one antibody molecule.
The problem of dissociating the TH-glycoprotein molecule in the presence of serum proteins that would compete for chemical dissociating agents was solved by subjecting the sample to ultrasonication, and this procedure has been incorporated as part of the assay although so far it has not altered the results that were obtained with normal serum when this step was omitted.
The question of whether the substance measured in the assay is identical with THglycoprotein cannot be. resolved until the material has been isolated from serum and analysed, a project rendered difficult by its very low concentration in serum. However, as far as these experiments are concerned the substance in serum behaved as if it were highmolecular-weight TH-glycoprotein. It was not absorbed from serum by immunoabsorbents prepared with normal rabbit gammaglobulin or TH-glycoprotein, whereas it was removed with a specific immunoabsorbent.
The antiserum used for these experiments satisfied the usual criteria for specificity by giving only one line on diffusion against prepared human TH-glycoprotein over a range of dilutions; in addition, specific antibodies were prepared from this serum for the radioimmunoassay.
In this study sera from ten apparently normal adults have been examined. The results indicate that TH-glycoprotein in some form is present in normal serum in a fairly wide range of concentrations. Studies involving larger groups of normal serum and sera from patients with kidney and other inflammatory diseases are at present being conducted. 
